[1] Hehr A et al. Präimplantationsdiagnostik. Med Gen 2014; 26: 417–26.

[2] Li N et al. The performance of whole genome amplification methods and next-generation sequencing for pre-implantation genetic diagnosis of chromosomal abnormalities. J Genet Genomics 2015; 42:151–9.

[3] Taylor TH et al. The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans. Hum Reprod Update2014; 20:571–81.

[4] Konstantinidis M et al. Live births following karyomapping of human blastocysts: experience from clinical application of the method. Reprod Biomed Online 2015; 31:394–403.

[5] Harton GL et al. ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod 2010; 26:33–40.

[6] Klein HG et al. Update der AG Reproduktionsgenetik der DGRM zur Präimplantationsdiagnostik (PID) in Deutschland. J Reproduktionsmed Endokrinol_Online 2016; 13 (1):13-17.

[7] Davies MJ et al. Reproductive technologies and risk of birth defects. N Engl J Med 2012; 366: 803–13.

[8] Pressemitteilung Nr. 53/GP, 09.03.2016, www.stmgp.bayern.de